Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Itiviti introduces certification solution for FIX order flows to ensure timely MiFID II compliance

–      New Itiviti MiFID II Certification Solution facilitates testing of FIX order flow and re-certification. –      Delivered as a deployed solution or as a managed service integrated with existing test facilities. –      MiFID II compliance requires changes to nearly all FIX order flows. Stockholm, Sweden, April 24, 2017 – Itiviti, a world-leading technology provider for the capital markets industry, today announced the launch of Itiviti MiFID II Certification Solution, designed to facilitate onboarding and re-certification efforts for FIX protocol order flows, as required by the

ABB showcases latest power grid technologies at Hanover fair

April 24, 2017 - Highlights include latest HVDC innovations, digital substations and other smart solutions that build on ABB Ability™ offeringABB will showcase a wide range of innovative products, systems, software and service solutions  at the Hannover Messe in Germany from April 24 - 28, 2017, that are helping to shape the transformation of the power sector as part of the energy revolution. The increasing integration of intermittent renewables and distributed energy sources and new demand loads like data centers and electric vehicles, are bringing new challenges. The grid needs to

Sandvik chooses Etteplan as Preferred Partner

- Etteplan, an expert in engineering, embedded systems, IoT and technical documentation solutions and services, has signed a framework agreement with the engineering group Sandvik.After a thorough evaluation, Sandvik has chosen Etteplan as a partner for long-term collaboration involving technical consulting services. The companies have collaborated for ten years, and Etteplan has now been entrusted once again. The framework agreement applies to all Sandvik companies in Sweden and includes many different engineering disciplines, such as project management, mechanical design and machinery

Eurocine Vaccines has received notice of allowance for a US patent application

Eurocine Vaccines has received notice of allowance in the US for one of its patent applications. The patent application, involving the company´s nasal influenza vaccine candidate Immunose™ FLU, has been examined and is allowed for issuance as a patent.“We are pleased that one of our applications has been allowed by the U.S. Patent Office and we are encouraged to continue our systematic work to protect our rights”, said CSO Dr. Anna-Karin Maltais.  “This notice of allowance, in the world´s biggest pharmaceutical market, strengthens us in our discussions with potential partners and in our

Interim report, January-March 2017

Period January 1 – March 21, 2017 · Net sales SEK 94.7 m (SEK 87.3 m) · System revenue SEK 61.4 m (SEK 58.1 m) · Recurring revenue SEK 47.5 m (SEK 44.8 m) · EBITDA SEK 18.8 m (SEK 16.4 m) · EBITDA margin 19.8 % (18.8 %) · EBITDA-adj. SEK 9.1 m (SEK 5.9 m) · EBIT SEK 4.4 m (SEK 2.8 m) · Net profit SEK 2.8 m (SEK 1.4 m) · EPS before dilution SEK 0.05 (SEK 0.02) · Cash flow from operating activities SEK 13.7 m (SEK 13.4 m) For additional information, contact:Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85 For the full report, see

Fortum Charge & Drive and OP increase electric car charging stations by a third in Finland

ONLINE NEWS 24 APRIL 2017Fortum Charge & Drive and OP Financial Group are joining forces to build 100 electric car charging stations in different parts of Finland. To begin with, they have agreed to introduce charging stations to a total of about 80 locations. This means that the number of public charging stations in Finland will increase by about a third. The purpose of this partnership is to have a charging station in the vicinity of as many OP cooperative banks as possible.OP’s new strategy is to expand from the field of pure financial operations to provide a diversity of services. One

Beijer Ref Q1 2017

A good start to the yearNet sales in the first quarter of 2017 increased by 13 percent compared with the same period last year, amounting to SEK 2,218 million (1,967). The increase is due to acquisitions and good growth on the European markets. The OEM and Comfort Cooling market areas have enjoyed a strong start to the year. The Commercial Cooling market area is stable. The operating profit for the first quarter of 2017 was SEK 107 million (89). This is an increase of 20 percent compared to the same period last year. The profit for the period was SEK 72 million (61), an increase of

Episurf Medical AB will be exhibiting at 6. Berliner Knorpelsymposium held in Berlin, Germany, on May 5-6

Episurf Medical AB will participate at 6. Berliner knorpelsymposium (6th Berlin Cartilage Symposium), an orthopaedic conference held in Berlin, Germany, (Humboldt Carré) on May 5-6. For full program, see link.  . For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences). For more information, please contact: Pål Ryfors, acting CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About

NattoPharma ASA : Invitation to Annual General Meeting 2017

The Board of Directors of NattoPharma ASA (the "Company") hereby convenes an Annual General Meeting 15 May 2017 at 15:00 hours (CET) at the Company's office in Lilleakerveien 2B, 0283 Oslo. Please see enclosed Notice of Annual General Meeting and Agenda, supporting documents can be found at the company website, www.nattopharma.com. For further information, please contact; Kjetil Ramsøy CFO - NattoPharma ASA Email: kjetil.ramsoy@nattopharma.com

Opus Inspection Acquires European RSLab

Opus Inspection has acquired 60% of Remote Sensing Laboratory S.L. (RSLab), the Madrid based, ISO 17025 accredited laboratory for the remote measurement of real-driving emissions.  The company will be renamed Opus RS Europe S.L. and will lead Opus’ commercial Remote Sensing activities in Europe.RSLab has represented Opus’ Remote Sensing technology in European markets since 2007, and has conducted numerous on-road emissions studies using Remote Sensing.  Josefina de la Fuente, Founder of RSLab, will continue to serve as General Manager of the company.  “We are excited about RSLab joining

Notice of stabilization measures in ChromoGenics during the period 23 March to 21 April 2017 on Nasdaq First North, Stockholm

NOT FOR DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, TO NEW DISTRIBUTORS IN THE UNITED STATES OR FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE ILLEGAL BY APPLICABLE LAWChromoGenics AB (publ) announces that stabilizing trading by Erik Penser AB ("EPB") in ChromoGenics’ shares on Nasdaq First North, Stockholm has ended. The stabilization period in connection with the listing of the shares in ChromoGenics AB on Nasdaq First North

Update on the development of simeprevir as part of the triple combination with AL-335 and odalasvir (JNJ-4178)

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today communicates an update on the status of the development of JNJ-4178, the triple combination of simeprevir, odalasvir and AL-335, following The International Liver Congress™ 2017 of the European Association for the Study of the Liver (EASL), which was held in Amsterdam, on 19-23 April. Data from an ongoing phase II study presented at The International Liver Congress™ 2017 demonstrate that this regimen has the potential to shorten treatment duration, offer high efficacy and is generally well tolerated in those whose disease is

Evolution to deliver bespoke Dual Play Roulette at Grand Casino Bucharest

Evolution Gaming, leading provider of Live Casino solutions, has announced that it will install a bespoke Dual Play Roulette at the Grand Casino Bucharest.The Evolution Dual Play Roulette table, which brings together land-based and online play, will be located on the casino’s main gaming floor, on the ground floor of the JW Marriott Bucharest Grand Hotel. It follows Dual Play Roulette launches in the past 18 months at The Ritz Club London, The Hippodrome Casino London and Malta’s Dragonara Casino. Evolution Dual Play Roulette embodies land-based and online casino convergence by allowing

Skanska builds power plant in Høyanger municipality, Norway, for NOK 350M, about SEK 370M

Skanska has signed a contract with SFE Produksjon to build Østerbø power plant in the municipality of Høyanger, Norway. The contract is worth NOK 350M, about SEK 370M, which will be included in the Nordic order bookings for the second quarter of 2017.The project includes an about 7.1 kilometer long tunnel in the mountain, drilling of shafts, blasting for the power plant and concrete work in the power station. The area in which the power plant is built has particularly good conditions for hydropower, with a natural water reservoir with high storage capacity. Several workplaces will only be

Atea Norway signs contract with 3 counties and 24 municipalities

Atea Norway signs contract with the counties Buskerud, Telemark and Vestfold and 24 municipalities for delivery of clients and related products. The contract runs for 2 years with an option for renewal of additional 2 years with an estimated annual value of NOK 85 million.The contract is a renewal and constitutes a framework agreement with the 3 counties and 24 municipalities in Buskerud and Telemark. Atea is the sole supplier of clients to these counties and municipalities. “Atea had the best offer among the suppliers that competed in the tendering process, which shows that they are

Interim report January - March 2017

In the first quarter, Byggmax increased net sales by +6,1%January 1 - March 31 · Net sales amounted to SEK 782.6 M (737.9), up 6.1 percent. · Net sales for comparable stores increased 0.2 percent (increased 5.3). · The gross margin was 30.3 percent (31.2). · EBITDA amounted to a negative SEK 23.5 M (negative 24.2). · The EBITDA margin was a negative 3.0 percent (negative 3.3). · EBIT amounted to a negative SEK 61.9 M (negative 57.8). · The loss after tax was SEK 51.6 M (loss 58.2). · Earnings per share totaled a negative SEK 0.8 (negative 1.0).

Capio acquires a Swedish eye specialist clinic in Stockholm

Capio has signed an agreement to acquire 100% of the shares in Globen Ögonklinik (PanSyn Sweden AB, including subsidiaries) (“Globen”). The clinic is specialized in ophthalmology and offers complex eye treatments, including cataract surgery, RLE (Refractive Lens Exchange) and refractive laser treatments. Net sales in 2016 were MSEK 75.Globen provides ophthalmology treatments at two locations in the southern part of Stockholm and performs annually about 36,000 consultations and 4,600 surgeries. The clinic serves both public and private pay patients, with its main focus being on supporting

Handelsbanken’s interim report for January-March 2017 will be presented on April 26

Handelsbanken will present its results for January­‑March 2017 in Stockholm on April 26, 2017, at 9:00 a.m. CET, at a meeting with the media and analysts. The interim report for January‑March 2017 will be published at 7:00 a.m. CET, on April 26, 2017. A telephone conference will be held at 11:00 a.m. CET (5:00 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203-364 5374Swedish number: +46 8-505 564 74US number: +1 855-753 2230 Instructions1.     Dial +xx xxx xx 10

Invitation to presentation of Serneke Group’s first quarter report 2017

Serneke Group AB will publish its interim report for January–March 2017 on Wednesday, 3 May 2017 at approximately 6:45 p.m. CET. A conference call and web presentation for investors, analysts and media will be held on Thursday, 4 May, at 11:00 a.m. CET. The CEO, Mr. Ola Serneke and the CFO, Mrs. Camilla Heyman, will present and comment the report as well as answer questions following the presentation. The presentation will be held in Swedish via a telephone conference and a live webcast will be available on www.serneke.group/en/investor-relations 

Wilson Therapeutics presented positive final Phase 2 data for WTX101 at EASL Annual Meeting

Wilson Therapeutics AB (publ), announced today that the final data from the company’s Phase 2 trial of WTX101 (bis-choline tetrathiomolybdate), an investigational first-in-class copper modulating agent with a unique mode of action for the treatment of patients with Wilson Disease, were presented as a late breaker presentation at The International Liver Congress™ 2017. The congress is the Annual Meeting of the European Association for the Study of the Liver (EASL), held in Amsterdam, the Netherlands, 19 - 23 April. The data were presented by Prof. Karl Heinz Weiss, MD, University of

REPORT ON THE FIRST QUARTER 2017

Strong sales growth and improved underlying EBIT FIRST QUARTER · Net sales for the first quarter totaled SEK 3,443 million (2,999); an increase of 15%, of which 11% was organic growth. · Operating profit (EBIT) before items affecting comparability amounted to SEK 418 million (400), representing a margin of 12.1% (13.3), including SEK 46 million of rebranding cost, class action legal costs and acquisition-related cost. · Operating profit (EBIT) amounted to SEK 418 million (400). · Cash flow for the period totaled SEK -384 million (-415). Operating cash flow totaled SEK -

Genel Energy plc Announces Directorate Change

24 April 2017 Genel Energy plc (‘Genel Energy’ or ‘the Company’) announces that Stephen Whyte has been appointed as an independent non-executive director and Chairman designate with immediate effect.  Tony Hayward will retire as a Director and Chairman of the Company at the conclusion of the 2017 AGM, to be held on 6 June 2017, at which point Stephen Whyte will take up the role of Chairman. Murat Özgül, Chief Executive of Genel, said: "It has been a great pleasure to have worked with Tony during his time at Genel. When we first started working together, the oil industry in the

Best start ever for Inwido

Inwido’s President and CEO, Håkan Jeppsson, comments the first quarter of 2017:“We have begun 2017 with our best first quarter to date in terms of earnings, sales and orders.”  “Operating profit rose to SEK 83 million (37) and total sales rose by 30 percent to SEK 1,365 million. This means that the rolling-12-month operating margin is now in line with our target of 12 percent.”  “Order bookings rose by 38 percent and the order backlog was 29 percent higher than at the same time in the preceding year.”  “At the same time, we must remember that the first quarter is our smallest

Interim report January-March 2017

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation and the Swedish Securities Market Act. The information was submitted by the below contact persons for publication on 24 April 2017 at 7:45 a.m. CET. Record-strong start to 2017 January - March 2017 · Net sales rose to SEK 1,365 million (1,048), representing an increase of 30 percent. Organic growth was 11 percent · Organic growth adjusted for closure of ProTec in Denmark amounted to 15% · EBITA increased to SEK 82 million (27) after items affecting

There are no items matching the current filter
There are no more items matching the current filter
Back to top